Q1 2023 Holdings
Filed 2023-05-15 | 81 holdings | $3.0B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Guardant Health Inc | NOTE 11/1 | 40131MAB5 | $168.8M | $250,022,000 | 5.6% |
| Exact Sciences Corp | NOTE 0.375% 3/0 | 30063PAC9 | $122.7M | $139,000,000 | 4.0% |
| Nanostring Technologies Inc | NOTE 2.625% 3/0 | 63009RAD1 | $121.8M | $145,520,000 | 4.0% |
| Novocure LTD | NOTE 11/0 | 67011XAB9 | $116.8M | $134,334,000 | 3.9% |
| Alphatec Hldgs Inc | NOTE 0.750% 8/0 | 02081GAB8 | $108.2M | $101,250,000 | 3.6% |
| Bridgebio Pharma Inc | NOTE 2.500% 3/1 | 10806XAB8 | $106.2M | $143,338,000 | 3.5% |
| Nevro Corp | NOTE 2.750% 4/0 | 64157FAC7 | $102.7M | $109,251,000 | 3.4% |
| Glaukos Corp(GKOS) | COM | 377322102 | $90.5M | 1,806,651 | 3.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $90.4M | 3,714,672 | 3.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $77.6M | 766,800 | 2.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $76.5M | 2,137,110 | 2.5% |
| Align Technology Inc(ALGN) | COM | 016255101 | $69.2M | 207,130 | 2.3% |
| Biogen Inc(BIIB) | COM | 09062X103 | $61.4M | 220,742 | 2.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $59.0M | 1,632,915 | 1.9% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $57.0M | 223,120 | 1.9% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $56.3M | 454,169 | 1.9% |
| Natera Inc(NTRA) | COM | 632307104 | $54.5M | 982,241 | 1.8% |
| Travere Therapeutics Inc | NOTE 2.500% 9/1 | 761299AB2 | $53.9M | $56,031,000 | 1.8% |
| Nuvasive Inc | NOTE 1.000% 6/0 | 670704AL9 | $51.1M | $51,500,000 | 1.7% |
| Karyopharm Therapeutics Inc | NOTE 3.000%10/1 | 48576UAA4 | $51.1M | $65,976,000 | 1.7% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $50.1M | 3,241,351 | 1.7% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $49.5M | 1,319,978 | 1.6% |
| Ionis Pharmaceuticals Inc | NOTE 4/0 | 462222AD2 | $48.1M | $52,740,000 | 1.6% |
| Exact Sciences Corp | NOTE 0.375% 3/1 | 30063PAB1 | $45.2M | $48,300,000 | 1.5% |
| Orthopediatrics Corp(KIDS) | COM | 68752L100 | $44.2M | 998,871 | 1.5% |
| DAY One Biopharmaceuticals I(DAWN) | COM | 23954D109 | $42.2M | 3,159,895 | 1.4% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $42.0M | 1,038,310 | 1.4% |
| Amyris Inc | NOTE 1.500%11/1 | 03236MAJ0 | $39.1M | $137,850,000 | 1.3% |
| Amgen Inc(AMGN) | COM | 031162100 | $39.0M | 161,500 | 1.3% |
| Insmed Inc | NOTE 1.750% 1/1 | 457669AA7 | $36.5M | $39,963,000 | 1.2% |
| Neogenomics Inc | NOTE 0.250% 1/1 | 64049MAB6 | $36.0M | $48,678,000 | 1.2% |
| Ionis Pharmaceuticals Inc | NOTE 0.125%12/1 | 462222AB6 | $33.8M | $36,533,000 | 1.1% |
| Nuvasive Inc | NOTE 0.375% 3/1 | 670704AJ4 | $32.5M | $36,665,000 | 1.1% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $32.4M | 2,019,714 | 1.1% |
| Outset MED Inc(OMGBP) | COM | 690145107 | $32.3M | 1,754,350 | 1.1% |
| Neogenomics Inc | NOTE 1.250% 5/0 | 64049MAA8 | $31.0M | $33,000,000 | 1.0% |
| Harrow Health Inc(HROW) | COM | 415858109 | $30.7M | 1,452,538 | 1.0% |
| Penumbra Inc(PEN) | COM | 70975L107 | $29.8M | 107,044 | 1.0% |
| Bellus Health Inc New(BLU) | COM NEW | 07987C204 | $29.7M | 4,126,194 | 1.0% |
| Legend Biotech Corp(LEGN) | SPONSORED ADS | 52490G102 | $29.0M | 601,801 | 1.0% |
| Dice Therapeutics Inc | COM | 23345J104 | $28.2M | 984,800 | 0.9% |
| Travere Therapeutics Inc | NOTE 2.250% 3/0 | 89422GAA5 | $27.9M | $28,350,000 | 0.9% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $27.9M | 348,036 | 0.9% |
| Bridgebio Pharma Inc | NOTE 2.250% 2/0 | 10806XAD4 | $27.4M | $42,294,000 | 0.9% |
| Merus N V | COM | N5749R100 | $27.1M | 1,473,084 | 0.9% |
| Hillevax Inc | COM | 43157M102 | $26.8M | 1,620,216 | 0.9% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $26.4M | 3,269,094 | 0.9% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $23.6M | 1,997,055 | 0.8% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $21.2M | 973,073 | 0.7% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $21.1M | 426,110 | 0.7% |